June 17, 2019
Xeris Pharmaceuticals Announces Additional Positive Outcomes from a Global Phase 3 Clinical Trial of Its Investigational Ready-to-Use Glucagon
Findings will support application for European marketing authorization and augment body of data supporting efficacy and utility of its ready-to-use,…